Saturday 17 October 2026 Export IOVA’s income statement to Excel — free account

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $263.5 million, up 60.6% from fiscal 2024. In the quarter to June 2026, revenue grew 65.7%, EPS grew 66.7% and free cash flow grew 11.5%, each against the same quarter a year earlier.

13.58 1.14 −7.74%

Follow IOVA

Alert me

Market cap: $6.7B
P/E: 0.0×
Fwd P/E: −7.8×
Dividend yield: —
F-score: 4/9
Altman Z: −2.30
Beneish M: −2.46
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	—	—	4	6
ROE Full definition →		(53.89%)	(55.50%)	(47.51%)	(40.36%)
ROA Full definition →		(41.94%)	(42.88%)	(37.40%)	(31.76%)
ROIC Full definition →		(64.83%)	(62.77%)	(55.59%)	(42.96%)
Return on Tangible Assets Full definition →		(92.48%)	(89.79%)	(75.53%)	(59.22%)
Average Days of Receivables Full definition →		97.31	114.21	104.48	114.70
Free Cash Flow per Share Full definition →		(0.97)	(0.94)	(0.73)	(0.66)
Free Cash Flow Full definition →		(351.82)	(336.24)	(305.02)	(296.39)
Capital Expenditures Full definition →		(28.68)	(33.84)	(34.23)	(32.21)
Other line items
Cash ROIC Full definition →		(35.07%)	(33.77%)	(29.47%)	(28.67%)
Accounts Receivable Turnover Full definition →		4.09	3.47	3.74	4.01
Accounts Payable Turnover Full definition →		4.87	6.97	5.25	5.76
Inventory Turnover Full definition →		3.39	3.36	2.79	3.18
Average Days of Payables Full definition →		74.44	46.70	79.03	57.05
Days of Inventory on Hand Full definition →		123.22	108.92	123.19	121.01
Tax Rate Full definition →		0.00	(0.01)	0.00	(0.01)
Research and Development Expense of Revenue Full definition →		118.36%	113.95%	100.41%	82.38%
Selling, General and Administrative Expense of Revenue Full definition →		63.05%	57.81%	51.63%	45.90%
Share Based Compensation of Revenue Full definition →		32.24%	23.37%	17.48%	14.38%
Operating CF/Net income Full definition →		0.81	0.77	0.77	0.91
Depreciation/Fixed assets Full definition →		0.34	0.31	0.30	0.30
Capex/Depreciation Full definition →		(0.66)	(0.84)	(0.86)	(0.82)
Revenue per Share Full definition →		0.69	0.74	0.68	0.72
Operating CF per Share Full definition →		(0.89)	(0.85)	(0.65)	(0.59)
Capex per Share Full definition →		(0.08)	(0.09)	(0.08)	(0.07)
Capex to Sales Full definition →		0.11	0.13	0.12	0.10

Show all line items

Columns are period end dates

Stockrow Weekly